Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RRMM”

147 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 147 results

Testing effectiveness (Phase 2)Looking for participantsNCT06920251
What this trial is testing

Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy

Who this might be right for
Relapsed Refractory Multiple Myeloma (RRMM)
Seoul National University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT04412707
What this trial is testing

A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients

Who this might be right for
RRMM
Oncopeptides AB 27
Large-scale testing (Phase 3)Active Not RecruitingNCT05405166
What this trial is testing

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM

Who this might be right for
Plasma Cell Myeloma Recurrent
Sanofi 531
Testing effectiveness (Phase 2)Looking for participantsNCT06484829
What this trial is testing

Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma (RRMM)
Chengdu Zenitar Biomedical Technology Co., Ltd 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT05911321
What this trial is testing

Isa-Pom-Dex in Elderly/Frail Subjects With RRMM

Who this might be right for
Multiple MyelomaRelapseRefractory+2 more
UNC Lineberger Comprehensive Cancer Center 6
Very early researchActive Not RecruitingNCT05838131
What this trial is testing

Study of CT071 Injection in RRMM or PPCL

Who this might be right for
Multiple MyelomaPrimary Plasma Cell Leukemia
Shanghai Changzheng Hospital 20
Early research (Phase 1)WithdrawnNCT04998747
What this trial is testing

Subcutaneous (SC) AMG 701 in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Amgen
Large-scale testing (Phase 3)Active Not RecruitingNCT05552976
What this trial is testing

Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Bristol-Myers Squibb 525
Early research (Phase 1)Study completedNCT03143985
What this trial is testing

Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Koen van Besien 18
Large-scale testing (Phase 3)Active Not RecruitingNCT04939142
What this trial is testing

Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Antengene Corporation 150
Large-scale testing (Phase 3)Looking for participantsNCT05519085
What this trial is testing

Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Celgene 810
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06333509
What this trial is testing

Anti-GPRC5D CAR-T Cells (CT071) in Participants With RRMM or RRpPCL

Who this might be right for
Multiple MyelomaPrimary Plasma Cell Leukemia
CARsgen Therapeutics Co., Ltd. 166
Testing effectiveness (Phase 2)Study completedNCT07102706
What this trial is testing

Phase I Trial of GR1803 Injection in Patients With RRMM

Who this might be right for
Multiple Myeloma (MM)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 76
Not applicableActive Not RecruitingNCT06479954
What this trial is testing

Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Pfizer 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT07084896
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 106
Early research (Phase 1)Study completedNCT04000282
What this trial is testing

First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Sanofi 37
Not applicableStudy completedNCT02555839
What this trial is testing

Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

Who this might be right for
Multiple Myeloma
Celgene 127
Testing effectiveness (Phase 2)Active Not RecruitingNCT07217119
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Feladilimab (GSK3359609) in Participants With RRMM

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 25
Testing effectiveness (Phase 2)Study completedNCT02045017
What this trial is testing

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

Who this might be right for
Multiple Myeloma
Celgene 81
Not applicableNot Yet RecruitingNCT07391761
What this trial is testing

A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan

Who this might be right for
Refractory Multiple Myeloma (RRMM)
Pfizer 30
Load More Results